BTK and pemphigus: Furthermore, low MW inhibitors of Bruton tyrosine kinase (BTK), which is essential for B cell activation and maturation (Corneth, Klein Wolterink, & Hendriks, 2016), have been successfully evaluated in a phase I clinical trial in pemphigus patients (Murrell, 2018).